These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33143219)

  • 1. Impacts of Multidrug-Resistant Pathogens and Inappropriate Initial Antibiotic Therapy on the Outcomes of Neonates with Ventilator-Associated Pneumonia.
    Wang HC; Liao CC; Chu SM; Lai MY; Huang HR; Chiang MC; Fu RH; Hsu JF; Tsai MH
    Antibiotics (Basel); 2020 Oct; 9(11):. PubMed ID: 33143219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcomes of neonates with polymicrobial ventilator-associated pneumonia in the intensive care unit.
    Wang HC; Tsai MH; Chu SM; Liao CC; Lai MY; Huang HR; Chiang MC; Fu RH; Hsu JF
    BMC Infect Dis; 2021 Sep; 21(1):965. PubMed ID: 34535089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-Resistant Healthcare-Associated Infections in Neonates with Severe Respiratory Failure and the Impacts of Inappropriate Initial Antibiotic Therap.
    Hsu JF; Chu SM; Wang HC; Liao CC; Lai MY; Huang HR; Chiang MC; Fu RH; Tsai MH
    Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33919573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia.
    Depuydt PO; Vandijck DM; Bekaert MA; Decruyenaere JM; Blot SI; Vogelaers DP; Benoit DD
    Crit Care; 2008; 12(6):R142. PubMed ID: 19014695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinventing the wheel: Impact of prolonged antibiotic exposure on multidrug-resistant ventilator-associated pneumonia in trauma patients.
    Lewis RH; Sharpe JP; Swanson JM; Fabian TC; Croce MA; Magnotti LJ
    J Trauma Acute Care Surg; 2018 Aug; 85(2):256-262. PubMed ID: 29664891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventilator-associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes.
    Apisarnthanarak A; Holzmann-Pazgal G; Hamvas A; Olsen MA; Fraser VJ
    Pediatrics; 2003 Dec; 112(6 Pt 1):1283-9. PubMed ID: 14654598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of clinical severity index, infective pathogens, and initial empiric antibiotic use on hospital mortality in patients with ventilator-associated pneumonia.
    Tseng CC; Liu SF; Wang CC; Tu ML; Chung YH; Lin MC; Fang WF
    Am J Infect Control; 2012 Sep; 40(7):648-52. PubMed ID: 22243991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of incidence and risk factors of neonatal ventilator associated pneumonia in a hospital in Hunan Province, 2016-2018].
    Zhou YF; Luo JY; Quan QH; Li YM; Jiang H; Fu K
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Aug; 54(8):822-827. PubMed ID: 32842309
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: rationale and study protocol for a randomised controlled trial.
    Yoshimura J; Yamakawa K; Kinoshita T; Ohta Y; Morimoto T
    Trials; 2018 Nov; 19(1):614. PubMed ID: 30409160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and risk factors of ventilator-associated pneumonia in neonates.
    Thatrimontrichai A; Rujeerapaiboon N; Janjindamai W; Dissaneevate S; Maneenil G; Kritsaneepaiboon S; Tanaanantarak P
    World J Pediatr; 2017 Aug; 13(4):328-334. PubMed ID: 28120236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, clinical features, and implications on outcomes of neonatal late-onset sepsis with concurrent infectious focus.
    Wu IH; Tsai MH; Lai MY; Hsu LF; Chiang MC; Lien R; Fu RH; Huang HR; Chu SM; Hsu JF
    BMC Infect Dis; 2017 Jul; 17(1):465. PubMed ID: 28673280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of ventilator-associated tracheobronchitis and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria at a tertiary care hospital in Thailand.
    Kajeekul R; Thamlikitkul V; Wonglaksanapimon S; Rattanaumpawan P
    JAC Antimicrob Resist; 2024 Feb; 6(1):dlad140. PubMed ID: 38161966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Inchai J; Pothirat C; Bumroongkit C; Limsukon A; Khositsakulchai W; Liwsrisakun C
    J Intensive Care; 2015; 3():9. PubMed ID: 27408726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of 14-day mortality in multidrug-resistant Acinetobacter baumannii in ventilator-associated pneumonia.
    Almomani BA; McCullough A; Gharaibeh R; Samrah S; Mahasneh F
    J Infect Dev Ctries; 2015 Dec; 9(12):1323-30. PubMed ID: 26719938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors and etiological analysis of ventilator-associated pneumonia: three year's cases analysis of intensive care unit in county hospital].
    Hu Z; Zhou S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Oct; 30(10):933-938. PubMed ID: 30439311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventilator-associated pneumonia in a tertiary care hospital in India: role of multi-drug resistant pathogens.
    Joseph NM; Sistla S; Dutta TK; Badhe AS; Rasitha D; Parija SC
    J Infect Dev Ctries; 2010 May; 4(4):218-25. PubMed ID: 20440059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU.
    Tsai MH; Chu SM; Hsu JF; Lien R; Huang HR; Chiang MC; Fu RH; Lee CW; Huang YC
    Pediatrics; 2014 Feb; 133(2):e322-9. PubMed ID: 24420803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy.
    Maruyama T; Fujisawa T; Ishida T; Ito A; Oyamada Y; Fujimoto K; Yoshida M; Maeda H; Miyashita N; Nagai H; Imamura Y; Shime N; Suzuki S; Amishima M; Higa F; Kobayashi H; Suga S; Tsutsui K; Kohno S; Brito V; Niederman MS
    Clin Infect Dis; 2019 Mar; 68(7):1080-1088. PubMed ID: 30084884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.